Vitamin A supplementation in late pregnancy can decrease the incidence of bronchopulmonary dysplasia in newborns

Area of Science:

• Neonatal Medicine
• Respiratory Medicine
• Nutritional Science

Background:

• Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants, often linked to prematurity and mechanical ventilation-induced lung injury.
• Current BPD prevention relies on postnatal Vitamin A administration, but antenatal supplementation is unexplored.
• Vitamin A deficiency in pregnancy is associated with adverse neonatal outcomes, including low birth weight and anemia.

Purpose of the Study:

• To hypothesize that Vitamin A supplementation during late pregnancy can reduce the incidence of bronchopulmonary dysplasia (BPD) in newborns.
• To evaluate the potential of antenatal Vitamin A as an adjunct to current postnatal BPD preventive therapies.
• To address widespread vitamin A deficiency in pregnant mothers and newborns in developing regions.

Main Methods:

• The study proposes a hypothesis based on existing knowledge of Vitamin A's role in lung development and its safety in late pregnancy.
• It suggests combining antenatal maternal supplementation with postnatal newborn supplementation.
• The approach leverages animal model findings on Vitamin A's upregulation of lung growth genes and surfactant production.

Main Results:

• Vitamin A supplementation in late pregnancy is hypothesized to increase cord blood Vitamin A levels.
• This antenatal supplementation is predicted to complement postnatal therapy for more effective BPD prevention.
• The strategy is expected to mitigate risks associated with vitamin A deficiency during pregnancy.

Conclusions:

• Antenatal Vitamin A supplementation represents a promising strategy to decrease BPD incidence.
• Combining maternal and newborn Vitamin A supplementation offers a potentially superior preventive approach.
• This intervention can simultaneously address maternal and neonatal vitamin A deficiency, improving overall health outcomes.